BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24372850)

  • 1. Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study.
    Hsu JW; Lirng JF; Wang SJ; Lin CL; Yang KC; Liao MH; Chou YH
    Bipolar Disord; 2014 May; 16(3):241-8. PubMed ID: 24372850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the serotonin transporter and cytokines: Implications for the pathophysiology of bipolar disorder.
    Chou YH; Hsieh WC; Chen LC; Lirng JF; Wang SJ
    J Affect Disord; 2016 Feb; 191():29-35. PubMed ID: 26630394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neither cortisol nor brain-derived neurotrophic factor is associated with serotonin transporter in bipolar disorder.
    Chou YH; Lirng JF; Hsieh WC; Chiu YC; Tu YA; Wang SJ
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):280-287. PubMed ID: 26706694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study.
    Chou YH; Wang SJ; Lin CL; Mao WC; Lee SM; Liao MH
    Bipolar Disord; 2010 May; 12(3):312-8. PubMed ID: 20565438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggression in bipolar II disorder and its relation to the serotonin transporter.
    Chou YH; Lin CL; Wang SJ; Lirng JF; Yang KC; Chien Chang A; Liao MH
    J Affect Disord; 2013 May; 147(1-3):59-63. PubMed ID: 23123132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the Serotonin Transporter Availability Among Male Cigarette Smokers: A SPECT Study With [123I] ADAM.
    Zhao RJ; Lin SH; Lee LT; Lee IH; Chen PS; Chen KC; Yang YK
    J Addict Med; 2016; 10(2):89-92. PubMed ID: 26742023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.
    Catafau AM; Perez V; Plaza P; Pascual JC; Bullich S; Suarez M; Penengo MM; Corripio I; Puigdemont D; Danus M; Perich J; Alvarez E
    Psychopharmacology (Berl); 2006 Dec; 189(2):145-53. PubMed ID: 17033844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cognition in bipolar I disorder: the roles of the serotonin transporter and brain-derived neurotrophic factor.
    Chou YH; Wang SJ; Lirng JF; Lin CL; Yang KC; Chen CK; Yeh CB; Liao MH
    J Affect Disord; 2012 Dec; 143(1-3):131-7. PubMed ID: 22889524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers.
    Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Schmidl-Mohl B; Wenzel T; Demal U; Zettinig G; Hornik K; Thau K
    Neuropsychopharmacology; 2007 Aug; 32(8):1661-8. PubMed ID: 17192774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study.
    Yang KC; Liu MN; Liou YJ; Hu LY; Yang BH; Chou YH
    J Psychiatr Res; 2021 Mar; 135():174-180. PubMed ID: 33493946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.
    Hesse S; Müller U; Lincke T; Barthel H; Villmann T; Angermeyer MC; Sabri O; Stengler-Wenzke K
    Psychiatry Res; 2005 Oct; 140(1):63-72. PubMed ID: 16213689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.
    Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Wenzel T; Zettinig G; Hornik K; Pirker W; Thau K
    Neuropsychopharmacology; 2008 Dec; 33(13):3126-34. PubMed ID: 18354388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
    Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serotonin transporter availability in the brainstem of migraineurs.
    Schuh-Hofer S; Richter M; Geworski L; Villringer A; Israel H; Wenzel R; Munz DL; Arnold G
    J Neurol; 2007 Jun; 254(6):789-96. PubMed ID: 17351723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of the serotonin transporter in patients with alcohol dependence.
    Ho PS; Shih MC; Ma KH; Huang WS; Ho KK; Yen CH; Lu RB; Huang SY
    World J Biol Psychiatry; 2011 Mar; 12(2):134-42. PubMed ID: 20642399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
    Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
    J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transporter availability may moderate the association between perceiving stress and depressive tendencies - A SPECT with 5-HTTLPR genotyping study.
    Lin SH; Lee IH; Chen KC; Chen PS; Chiu NT; Yao WJ; Yang YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():24-9. PubMed ID: 25816791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain and platelet serotonin transporter in humans-correlation between [123I]-ADAM SPECT and serotonergic measurements in platelets.
    Uebelhack R; Franke L; Herold N; Plotkin M; Amthauer H; Felix R
    Neurosci Lett; 2006 Oct; 406(3):153-8. PubMed ID: 16934400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.